UK markets close in 41 minutes

ProKidney Corp. (PROK)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
2.1850+0.0250 (+1.16%)
As of 10:45AM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 132.79M
Enterprise value -225.74M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)91.32
Enterprise value/revenue N/A
Enterprise value/EBITDA 1.80

Trading information

Stock price history

Beta (5Y monthly) 1.29
52-week change 3-76.65%
S&P500 52-week change 323.57%
52-week high 313.5100
52-week low 31.1200
50-day moving average 31.7641
200-day moving average 33.8063

Share statistics

Avg vol (3-month) 3747.41k
Avg vol (10-day) 31.07M
Shares outstanding 561.62M
Implied shares outstanding 6173.38M
Float 844.25M
% held by insiders 122.12%
% held by institutions 158.35%
Shares short (15 Apr 2024) 411.56M
Short ratio (15 Apr 2024) 418.53
Short % of float (15 Apr 2024) 418.84%
Short % of shares outstanding (15 Apr 2024) 418.76%
Shares short (prior month 15 Mar 2024) 414.61M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-20.18%
Return on equity (ttm)-30.22%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -147.67M
Net income avi to common (ttm)-35.47M
Diluted EPS (ttm)-0.5700
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)362.95M
Total cash per share (mrq)5.89
Total debt (mrq)4.41M
Total debt/equity (mrq)1.13%
Current ratio (mrq)14.94
Book value per share (mrq)-18.43

Cash flow statement

Operating cash flow (ttm)-90.07M
Levered free cash flow (ttm)-77.08M